Breast cancer is commonly classified into four major clinical subtypes according to the presence or absence of molecular markers for estrogen receptor (ESR), progesterone receptor (PGR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene PGR and breast cancer.